The BIOKÉ webshop is under construction until January 2nd, 2017. We wish you a successful 2017!
Every year BIOKÉ speaks at professional seminars and comes to world wide exhibitions in the life science industry.
Are you eager to meet us? On the left sidebar our events calendar is shown, hope to see you next time!
CHELMSFORD, Mass., October 5th, 2017 – Brooks Automation, Inc. announced today that it has acquired 4titude, Ltd., a privately-held manufacturer of scientific consumables for biological sample materials used in a variety of genomic and DNA analytical applications. Based in Surrey, England and over 12 years of operations and approximately 85 employees, 4titude is widely recognized for its innovative range of Polymerase Chain Reaction (PCR) plates, seals and related bench-top instrumentation. 4titude has delivered consistent growth over the last 5 years with sales and distribution globally to 1200 customers in 50 different countries.
Danvers, MA – September 5, 2017 – Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services, has announced changes in part of its European operations. On January 1st, 2018, CST will now deal directly with its customers in Germany and Austria.
August 18, 2017 State College PA - SoftGenetics announced that it has purchased the assets of Mitotyping Technologies, originally founded by Terry Melton, from Health Network laboratories of Allentown PA. The addition of Mitotyping Technologies furthers SoftGenetics goal of becoming a dominant source to the world-wide DNA forensic community, which in addition to Mitotyping Technologies includes software tools for STR Analysis, Mitochondrial and STR analysis of nextgeneration data and the soon to be released MaSTR™ continuous mixture probabilistic software.
July 13, 2017 - Registration is now open for ACEA’s 5th Annual Cardio Symposium on September 23rd, 2017, immediately prior to the 2017 SPS Meeting in Berlin (Germany).
The meeting will begin with registration and lunch starting at 11am with presentations to follow until 7pm. The evening will end with a cocktail reception.
IPSWICH, MA, USA (August 1, 2017) — Detecting a specific DNA sequence outside of the laboratory, without bulky equipment or even electricity, may seem unlikely. However, astronauts aboard the International Space Station (ISS) did just that using a technique developed by New England Biolabs (NEB).
IPSWICH, Mass. and HEIDELBERG, Germany, July 25, 2017 /PRNewswire/ -- The EMBL Advanced Training Centre (ATC) welcomes New England Biolabs (NEB®) as its newest member of their Corporate Partnership Programme. Founded in the mid-1970s as a collective of scientists committed to developing innovative products for the life sciences industry, NEB is a recognized world leader in the discovery, development and commercialization of recombinant and native enzymes for genomic research.
Ipswich, MA, USA and Norwich, UK (June 7th, 2017) – In its mission to tackle global challenges through life science research, the Earlham Institute (Norwich, UK) faces unique problems raised through the sheer breadth of biological samples that it works with. Samples that the institute processes can come from any number of species of plant, animal, or microbial organism.
VIVIAN CAO JUNE 14, 2017 - ACEA Biosciences today announced the completion of its Phase 1 clinical study of AC0058, a novel irreversible Bruton’s Tyrosine Kinase (BTK) inhibitor, which is in development for the treatment of B cell-related autoimmune diseases, including rheumatoid arthritis and systemic lupus erythematosus. Fifty-six (56) healthy subjects participated in the double-blind, placebo-controlled trial, which......
IPSWICH, Mass., May 30, 2017 - The kits are compatible with poly(A) mRNA isolation and ribosomal RNA (rRNA) depletion, and libraries can be constructed from a substantially broader input range (5 ng to 1 µg of total RNA) at high yields. New Ultra II technology addresses lower input amounts and challenging sample types for Illumina® next generation sequencing systems.
ROSWELL, Ga. June 13, 2017 – As a life sciences company, Cell Signaling Technology (CST) uses about 200,000 pairs of gloves each year. But that glove waste no longer goes into a landfill. CST diverts it through an innovative program that has enabled the company to recycle more than 4,400 pounds of gloves, which are then turned into flower pots, lawn furniture, and other products.
SAN DIEGO, May 3, 2017 - The NovoCyte system with its updated software and firmware provides broader versatility and flexibility with its multi-option optical configuration capabilities. This update also brings the release of the new ACEA NovoCyte 3005 3 lasers system that provides up to 17 parameters including forward and side scatter.
LEIDEN, April 3, 2017 - BIOKÉ, a business unit of Cell Signaling Technology Europe (CST Europe), and Bethyl Laboratories, Inc. announced that they have signed an agreement allowing BIOKÉ to exclusively distribute Bethyl’s products in the BeNeLux countries, effective immediately.
LEIDEN, March 22, 2017 - BIOKÉ, a business unit of Cell Signaling Technology Europe (CST Europe), and ACEA Biosciences, Inc., a high performance cell analysis platforms manufacturer, announced their partnership to exclusively distribute ACEA’s xCELLigence® Cell Analyzer in the BeNeLux countries, effective immediately.
February 10, 2017, Danvers, MA — Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services, was honored with the 2017 CiteAb Award for “PTM Antibody Company of the Year” and for a third year in a row with the award for “Researchers’ Choice.” CST was also a close runner-up for the “Antibody Company of the Year” award. The CiteAb Antibody Awards aim to celebrate the very best suppliers, reagents, and individuals in the research antibody sector, recognizing the efforts that are made to progress science.
January 26, 2017, State College PA - SoftGenetics announced the availability of its new GeneMarkerHTS software for analysis of the Mitochondrial Genome for Forensic and Clinical Research applications from High Throughput Sequencing systems. GeneMarkerHTS is believed to be the first commercially available software developed exclusively for analysis of NGS Mitochondrial sequencing, is applicable in many cases including mass disaster, missing person, as well as clinical disease research and forensic anthropology applications.
January 19, 2017, State College PA - SoftGenetics announced the availability of the latest version of ChimerMarker software. ChimerMarker software, automated chimerism analysis software, integrates speed and accuracy with a biologist‐friendly interface. The software can be used to monitor chimerism levels in both allogeneic and autologous stem cells transplant or hematopoietic stem ...
Gentbrugge, Belgium – October 10, 2016 - Trinean, the leading provider of microfluidic spectrophotometry platforms, today announces the launch of the new DropSense96. Built upon the highly successful DropSense96 platform, the improved features of the new DropSense96 make it superior to any other droplet UV/VIS reader currently on the market...
DANVERS, Mass - November 21, 2016 – Honored as a life science leader at the 2016 Life Science Industry Awards (LSIA), Cell Signaling Technology (CST), a worldwide provider of antibodies, received Best Customer Service for its outstanding commitment to antibody quality and customer satisfaction. The LSIA recognizes .......
LEIDEN, October 24, 2016 - BIOKÉ, a Cell Signaling Technology Europe (CST Europe) company, and ACEA Biosciences, Inc., a high performance cell analysis platforms manufacturer, announced their partnership to exclusively distribute ACEA’s NovoCyte™ Flow Cytometer in the BeNeLux countries, effective immediately.
June 13, 2016 - Cell Signaling Technology (CST), CST, a worldwide provider of antibodies, is providing four high school juniors from Boston North Shore communities—Gloucester, Lynn, Peabody and Salem—with $10,000 each to pursue a college education in a science-related program.
April 12, 2016 - Cell Signaling Technology, Inc. (CST), a worldwide provider of antibodies, released four new monoclonal antibodies relevant to the rapidly growing fields of immunometabolism and tumor immunology.
February 16, 2016 - EMQN integrates Trinean’s DropSense™ into its standards QC procedures and quality assessment schemes for Molecular Genetic Labs
January 12, 2016 - New products use significantly less plastic and recyclable packaging, while delivering best-in-class performance for nucleic acid purification.
April 14, 2016 - Novel target enrichment technology, compatible with low input amounts from challenging sample types, uses a one-day workflow
February 1, 2016 - Cell Signaling Technology (CST) CST was honored today with the 2016 CiteAb® Awards for “Researcher’s Choice” and for a second year in a row “Antibody Company of the Year.”. As a company of scientists, we are humbled and honored to have our efforts....
November 23, 2015 - Nestled between chickpea pasta and apartments for Los Angeles' homeless on Time magazine's list of the year's 25 best inventions is Fluidigm's Juno. The system cuts the time it takes to amplify DNA down to a handful of hours, Time says.
NOVEMBER 3, 2015, NATIONAL HARBOR, MD (US BUSINESS WIRE) Cell Signaling Technology, Inc. (CST), a worldwide provider of antibodies, announced today the release of 6 new monoclonal antibodies (mAb) for tumor immunology research. This announcement was made at the 30th annual meeting of the Society for Immunotherapy of Cancer (SITC) at National Harbor, MD November 4-8th, 2015.
June 25, 2015 - Fluidigm has launched the Callisto system, a fully automated and programmable microfluidic cell culture system that integrates multifactorial dosing in 32 individual chambers for simultaneous cell culture. This innovative new platform will revolutionize the way cell biologists develop in vitro cell models.